Related Experiment Videos
Monoclonal antibodies as therapeutics in oncology
Mohit Trikha1, Li Yan, Marian T Nakada
1Centocor Oncology Research, 200 Great Valley Parkway, Malvern, PA 19355, USA.
Abstract:
The specificity of antibodies has been harnessed to target cancer cells and the first therapeutic antibodies for use in oncology are now finding application in the clinic. Studies are currently under way to develop new and improved antibodies. Recent developments have been made in the identification of novel targets, including the use of genomic and proteomic technologies. Several methods are also being developed to enhance antibody efficacy.
Insights
Therapeutic antibodies are revolutionizing cancer treatment by targeting cancer cells. Ongoing research focuses on novel targets and enhancing antibody effectiveness for improved oncology outcomes.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Antibodies are increasingly utilized in oncology for targeted cancer cell therapy.
- The first therapeutic antibodies for cancer treatment are now in clinical use.
- Advancements in antibody development are crucial for improving cancer care.
Purpose of the Study:
- To review recent developments in therapeutic antibody research for oncology.
- To highlight novel target identification strategies.
- To discuss methods for enhancing antibody efficacy in cancer treatment.
Main Methods:
- Review of current literature on therapeutic antibodies in oncology.
- Analysis of genomic and proteomic technologies for target identification.
- Examination of emerging strategies to improve antibody efficacy.
Main Results:
- Therapeutic antibodies are established in clinical oncology.
- Novel cancer targets are being identified using advanced technologies.
- Methods to boost antibody effectiveness are under development.
Conclusions:
- Antibody specificity offers a powerful approach to cancer therapy.
- Continued research is vital for developing next-generation cancer antibodies.
- Enhancing antibody efficacy will further improve patient outcomes in oncology.